Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters

The SARS-CoV-2 Omicron variant has continued to evolve. XBB is a recombinant between two BA.2 sublineages, XBB.1 includes the G252V mutation, and XBB.1.5 includes the G252V and F486P mutations. XBB.1.5 has rapidly increased in frequency and has become the dominant virus in New England. The bivalent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasrado, Ninaad, Collier, Ai-ris Y., Miller, Jessica, Hachmann, Nicole P., Liu, Jinyan, Sciacca, Michaela, Wu, Cindy, Anand, Trisha, Bondzie, Esther A., Fisher, Jana L., Mazurek, Camille R., Patio, Robert C., Powers, Olivia, Rodrigues, Stefanie L., Rowe, Marjorie, Surve, Nehalee, Ty, Darren M., Korber, Bette, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900747/
https://www.ncbi.nlm.nih.gov/pubmed/36747640
http://dx.doi.org/10.1101/2023.01.22.525079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900747/
https://www.ncbi.nlm.nih.gov/pubmed/36747640
http://dx.doi.org/10.1101/2023.01.22.525079

Ejemplares similares